Precision BioSciences, Inc. (DTIL)

Precision BioSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	58	29	45	132	450	438
Market Cap Growth	-30.89%	-34.32%	-66.30%	-70.64%	2.74%	-37.95%
Enterprise Value	26	-42	-54	-53	301	345
Last Close Price	4.97	3.81	10.95	35.70	222.00	250.20
PE Ratio	-	4.08	-	-	-	-
PS Ratio	35.13	0.43	0.91	5.26	3.89	18.02
PB Ratio	1.70	0.52	2.36	2.19	4.93	9.85
P/TBV Ratio	1.75	0.52	2.41	2.21	5.05	10.17
EV/Sales Ratio	20.45	-	-	-	2.60	14.19
Debt / Equity Ratio	0.87	0.53	1.66	0.41	0.10	0.24
Asset Turnover	0.01	0.46	0.25	0.11	0.64	0.13
Quick Ratio	4.59	5.88	2.35	3.19	4.01	2.33
Current Ratio	5.18	6.34	2.73	3.34	4.50	2.47
Return on Equity (ROE)	-143.89%	19.05%	-107.26%	-96.19%	-45.14%	-119.30%
Return on Assets (ROA)	-41.00%	-11.04%	-13.74%	-17.32%	-13.61%	-35.62%
Return on Capital (ROIC)	-66.64%	-23.95%	-40.34%	-41.95%	-31.71%	-71.04%
Earnings Yield	-133.58%	24.52%	-137.79%	-84.55%	-6.80%	-24.91%
FCF Yield	-109.45%	-200.83%	-193.42%	-37.16%	-3.54%	-21.12%
Buyback Yield / Dilution	-78.38%	-79.20%	-31.11%	-49.77%	-12.79%	-23.91%

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q